The mutation is a 102 bp deletion in exon 1 of TTPA which is predicted to result in a protein that is truncated by 34 amino acids and which presumably leads to loss of function, accounting for the severe reduction in plasma α-Toc concentrations and retinopathy, reported to occur in ECS with RVED. This evidence concerns the gene TTPA and retinal disorder.